Skip to main content
  • 3564 Accesses

Zusammenfassung

Das Retinoblastom ist der häufigste maligne intraokulare Tumor des Kindesalters. Die Erkrankung betrifft ein Auge oder beide Augen. Sie kann sporadisch oder familiär gehäuft vorkommen. Die Inaktivierung beider Allele des Tumorsuppressorgens RB1 (Chromosom 13) ist Ursache für ein Retinoblastom. Individuen mit konstitutioneller Heterozygotie für eine Rb1-Mutation haben zusätzlich ein erhöhtes Risiko für die Entstehung unabhängiger Zweittumoren. Durch eine Kombination verschiedenster Therapiemethoden liegt die Heilungsrate bei rein intraokularer Erkrankung bei nahezu 100%, während bei Patienten mit disseminierter metastasierter Erkrankung erst in den letzten Jahren eine kurative Behandlung möglich wurde.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 34.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Abramson DH, Frank CM (1998) Second nonocular tumors in survivors of bilateral retinoblastoma: a possible age effect on radiation-related risk. Ophthalmology 105:573–579

    Article  PubMed  CAS  ISI  Google Scholar 

  • Anteby I et al (1998) Ocular and orbital complications following the treatment of retinoblastoma. Eur J Ophthalmol 8:106–111

    PubMed  CAS  Google Scholar 

  • Bellaton E et al (2003) Neoadjuvant chemotherapy for extensive unilateral retinoblastoma. Br J Ophthalmol 87:327–329

    Article  PubMed  CAS  Google Scholar 

  • Bornfeld N et al (1997) Preliminary results of primary chemotherapy in retinoblastoma. Klin Padiatr 209: 216–221

    Article  PubMed  CAS  Google Scholar 

  • Brehm A et al (1998) Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:598–601

    Google Scholar 

  • Chan HSL et al (1996) Combining cyclosporin with chemotherapy controls intraocular retinoblastoma without radiation. Clin Cancer Res 2:1499–1508

    PubMed  CAS  Google Scholar 

  • Chantada G et al (2004) Results of a prospective study for the treatment of retinoblastoma. Cancer 100: 834–842

    Article  PubMed  CAS  ISI  Google Scholar 

  • Donaldson SS et al (1993) Retinoblastoma. In: Pizzo PA, Poplack DG (eds) Princples and practice of pediatric oncology, 2nd ed, pp 683–96. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  • Doz F et al (1995) Etoposide and carboplatin in extraocular retinoblastoma: a study by the Societe Francaise d’Oncologie Pediatrique. J Clin Oncol 13:902–909

    PubMed  CAS  Google Scholar 

  • Draper GJ et al (1986) Second primary neoplasms in patients with retinoblastoma. Br J Cancer 53:661–671

    PubMed  CAS  Google Scholar 

  • Draper GJ et al (1992) Patterns of risk of hereditary retinoblastoma and applications to genetic counseling. Br J Cancer 66:211–219

    PubMed  CAS  Google Scholar 

  • Dunkel IJ et al (2000) Successful treatment of metastatic retinoblastoma. Cancer 89:2117–2121

    Article  PubMed  CAS  ISI  Google Scholar 

  • Ellsworth RM (1977) Retinoblastoma. Mod Probl Ophthalmol 18: 94–100

    PubMed  CAS  Google Scholar 

  • Eng C et al (1993) Mortality from second tumors among long-term survivors of retinoblastoma. J Natl Cancer Inst 85:1121–1128

    PubMed  CAS  Google Scholar 

  • Friend SH et al (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323:643–646

    Article  PubMed  CAS  ISI  Google Scholar 

  • Hauffa BP et al (1995) Growth and development in children and adolescents after surgery, irradiation and chemotherapy for retinoblastoma. Monatsschr Kinderheilkd 143:1091–1098

    Google Scholar 

  • Hermanek P et al (1987) TNM Klassifikation maligner Tumoren. Springer, Heidelberg Berlin New York

    Google Scholar 

  • Imhof S et al (1997) Second primary tumours in hereditary-and non-hereditary retinoblastoma patients treated with megavoltage external beam irradiation. Doc Ophthalmol 93:337–344

    PubMed  CAS  Google Scholar 

  • Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820–823

    PubMed  Google Scholar 

  • Kremens B et al (2003) High-dose chemotherapy with autologous stem cell rescue in children with retinoblastoma. Bone Marrow Transplant 31:281–284

    PubMed  CAS  ISI  Google Scholar 

  • Linn Murphree A (2005) Intraocular retinoblastoma: the case for a new group classification. Ophthalmol Clin North Am 18:41–53

    PubMed  CAS  Google Scholar 

  • Lohmann DR et al (1996) The spectrum of germ-line mutations in hereditary retinoblastoma. Am J Hum Genet 58: 940–949

    PubMed  CAS  Google Scholar 

  • Lohmann DR et al (1997) Molekulare Genetik und Diagnostik des Retinoblastoms. Ophthalmologe 94:263–267

    Article  PubMed  CAS  ISI  Google Scholar 

  • Magnaghi-Jaulin L et al (1998) Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601–605

    PubMed  CAS  ISI  Google Scholar 

  • McCormick B et al (1988) Radiation therapy for retinoblastoma: comparison of results with lens-sparing versus lateral beam techniques. Int J Radiat Oncol Biol Phys 15:567–574

    PubMed  CAS  Google Scholar 

  • Migdal C (1983) Bilateral retinoblastoma: the prognosis for vision. Br J Ophthalmol 67:592–595

    PubMed  CAS  Google Scholar 

  • Moll AC et al (1997) Second primary tumors in patients with retinoblastoma. A review of the literature. Ophthalmic Genet 18:27–34

    PubMed  CAS  ISI  Google Scholar 

  • Namouni F et al (1997) High-dose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study. Eur J Cancer 33: 2368–2375

    Article  PubMed  CAS  Google Scholar 

  • Paulino A (1999) Trilateral retinoblastoma. Cancer 86:135–141

    PubMed  CAS  ISI  Google Scholar 

  • Schipper J (1983) An accurate and simple method for megavoltage radiation therapy of retinoblastoma. Radiother Oncol 1:31–41

    PubMed  CAS  Google Scholar 

  • Schüler AO et al (2003) Thermochemotherapy in hereditary retinoblastoma. Br J Ophthalmol 87:90–95

    Google Scholar 

  • Shields CL et al (1994) Optic nerve involvement of retinoblastoma. Metastatic potential and clinical risk factors. Cancer 73:692–698

    PubMed  CAS  ISI  Google Scholar 

  • Shields CL et al (1997) Combined chemoreduction and adjuvant treatment for intraocular retinoblastoma. Ophthalmology 104:2101–2111

    PubMed  CAS  ISI  Google Scholar 

  • Shields CL et al (2001) Plaque radiotherapy for retinoblastoma: long-term tumor control and treatment complications in 208 tumors. Ophthalmology 108:2116–2121

    PubMed  CAS  ISI  Google Scholar 

  • Shields CL et al (2002) Chemoreduction for unilateral retinoblastoma. Arch Ophthalmol 120:1653–1658

    PubMed  Google Scholar 

  • Schvartzman E et al (1996) Results of a stage-based protocol for the treatment of retinoblastoma. J Clin Oncol 14:1532–1536

    PubMed  CAS  Google Scholar 

  • Vogel F (1979) Genetics of retinoblastoma. Hum Genet 52:1–54

    Article  PubMed  CAS  Google Scholar 

  • Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81:323–30

    Article  PubMed  CAS  ISI  Google Scholar 

  • Weintraub SJ et al (1995) Mechanisms of active transcriptional repression by the retinoblastoma protein. Nature 375:812–815

    Article  PubMed  CAS  ISI  Google Scholar 

  • Wilson TW et al (1996) Penetration of chemotherapy into vitreous is increased by cryotherapy and cyclosporine in rabbits. Arch Ophthalmol 114:1390–1395

    PubMed  CAS  Google Scholar 

  • Wong FL et al (1997) Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. JAMA 278: 1262–12

    Article  PubMed  CAS  ISI  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Wieland, R., Havers, W. (2006). Retinoblastome. In: Gadner, H., Gaedicke, G., Niemeyer, C., Ritter, J. (eds) Pädiatrische Hämatologie und Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-29036-2_67

Download citation

  • DOI: https://doi.org/10.1007/3-540-29036-2_67

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-03702-6

  • Online ISBN: 978-3-540-29036-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics